Pharming (PHAR) Gross Margin (2020 - 2026)
Pharming (PHAR) posted Gross Margin of 90.83% for Q1 2026, up 13.27% on a QoQ basis from 80.19% in Q4 2025, and up 135.0% year-over-year from 38.65% in Q1 2025.
Pharming (PHAR) Gross Margin (2020 - 2026) Analysis & Trends
Pharming's Gross Margin history runs 7 years deep, the most recent figure standing at 90.83% for Q1 2026.
- Quarterly Gross Margin rose 135.0% year-over-year to 90.83% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 91.9% (up 452.0% YoY) and the FY2025 annual result came in at 87.9%, down 19.0% from the prior year.
- Gross Margin was 90.83% for Q1 2026 at Pharming, up from 80.19% in the prior quarter.
- Across five years, Gross Margin topped out at 179802955665024.62% in Q4 2023 and bottomed at 80.19% in Q4 2025.
- A 5-year average of 10576647421177.33% and a median of 90.42% in 2023 frame the typical range for Gross Margin.
- Annual changes were most pronounced in 2023 — Gross Margin soared 2000000000 bps — and 2024, when it slumped 2000000000 bps.
- Pharming's Gross Margin stood at 92.52% in 2022, then surged by 2000000000 bps to 179802955665024.62% in 2023, then plunged by 100 bps to 88.66% in 2024, then decreased by 10 bps to 80.19% in 2025, then grew by 13 bps to 90.83% in 2026.
- Business Quant data shows PHAR's Gross Margin at 90.83% in Q1 2026, 80.19% in Q4 2025, and 92.7% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 88.95% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 86.85% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 91.79% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 90.68% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Pharming | 9.02 Bn | 8.96 Bn | 65.80 Mn | 90.83% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 90.83% |
| Dec 31, 2025 | 80.19% |
| Sep 30, 2025 | 92.70% |
| Jun 30, 2025 | 89.96% |
| Mar 31, 2025 | 89.48% |
| Dec 31, 2024 | 88.66% |
| Sep 30, 2024 | 90.91% |
| Jun 30, 2024 | 87.38% |
| Mar 31, 2024 | 84.91% |
| Dec 31, 2023 | 179,802,955,665,024.62% |
| Sep 30, 2023 | 87.56% |
| Jun 30, 2023 | 50,493,647.24% |
| Mar 31, 2023 | 90.42% |
| Dec 31, 2022 | 92.52% |
| Sep 30, 2022 | 95.76% |
| Jun 30, 2022 | 92.02% |
| Mar 31, 2022 | 89.48% |
| Dec 31, 2021 | -60.16% |
| Sep 30, 2021 | 88.64% |
| Jun 30, 2021 | 90.76% |